Nanotechnology Now - News Story: "Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?"

Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

September 13th, 2005

Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

Abstract:
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.

Source:
nano.cancer.gov

Bookmark:

Related Links

Ohio State University

National Cancer Institute

Related News Press

Possible Futures

The "Tipping Point" February 12th, 2014

UCF Researcher Bringing 3-D TV Back From The Dead February 12th, 2014

Diamond Defect Boosts Quantum Technology February 4th, 2014

Iran to Hold 2nd Prototype Nanotechnology Products Competition January 21st, 2014

Nanomedicine

Nano Labs Shareholder Update March 8th, 2014

MANA Research Highlight: Smart nanofibers to treat kidney failure March 6th, 2014

Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc. March 6th, 2014

First Look at How Individual Staphylococcus Cells Adhere to Nanostructures Could Lead to New Ways to Thwart Infections: Berkeley Lab-led research could guide the development of bacteria-resistant materials March 5th, 2014